Therefore our results indicate that green tea EGCG can sensitize ERα-negative breast cancer cells to respond to conventional anti-hormone therapy through reactivating ERα, which could provide a new avenue for therapeutical strategies of hormone-resistant breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.